NE
Therapeutic Areas
Shinpoong Pharm Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Pyramax® (Pyronaridine-Artesunate) | Uncomplicated Plasmodium falciparum Malaria | Marketed |
| Pyramax® | Uncomplicated Plasmodium vivax Malaria | Marketed/Clinical |
| Tropical Disease Drug Center Portfolio | Various Neglected Tropical Diseases | Research to Clinical |
| Pafuramidine | Pneumocystis Pneumonia | Phase III |